ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,775
0,17%
Bitcoin
59 720,83
1,01%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Molecular Templates Inc (MTEM)

  7. Molecular Templates Inc (MTEM) Actualités

MTEM Molecular Templates Inc

1,725
0,075 (4,55%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Molecular Templates Inc MTEM NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,075 4,55% 1,725 01:50:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,64 1,55 1,725 1,725 1,65
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/4/202414:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29/3/202413:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28/3/202413:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04/3/202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/2/202402:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
25/1/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:04EDGAR2Form 8-K - Current report
13/11/202322:13EDGAR2Form 8-K - Current report
13/11/202322:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
02/11/202321:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
01/11/202321:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:12GLOBEMolecular Templates to Participate in Upcoming Investor..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202322:12EDGAR2Form 8-K - Current report
06/10/202323:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/9/202323:01EDGAR2Form 8-K - Current report
28/9/202322:11GLOBEMolecular Templates Announces the Appointment of Dr...
12/9/202323:15EDGAR2Form ARS - Annual Report to Security Holders
12/9/202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202323:08EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202322:11EDGAR2Form 8-K - Current report
11/8/202322:12EDGAR2Form 8-K - Current report
11/8/202317:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
10/8/202315:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202314:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:09EDGAR2Form 8-K - Current report
10/8/202314:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
02/8/202322:16EDGAR2Form 8-K - Current report
02/8/202322:11GLOBEMolecular Templates Announces Executive Leadership Changes
18/7/202317:56EDGAR2Form DEF 14A - Other definitive proxy statements
13/7/202318:48EDGAR2Form 8-K - Current report
13/7/202314:14GLOBEMolecular Templates Announces Up to $40 Million Private..
30/6/202322:31EDGAR2Form PRE 14A - Other preliminary proxy statements
17/6/202302:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
01/6/202313:57GLOBEMolecular Templates Announces the FDA Removal of Partial..
26/5/202323:10GLOBEMolecular Templates to Present on Phase I Dose Escalation..
15/5/202322:13GLOBEMolecular Templates, Inc. Reports First Quarter 2023..

Dernières Valeurs Consultées

NASDAQ
MTEM
Molecular Templates
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés